IL1B and inflammatory bowel disease: We are unaware of any clinical trials that have examined the effect of quercetin in IBD; however, a clinical trial in healthy individuals with dysbiosis showed a marked reduction in various inflammatory markers such as IL-6, IL-1β, TNF-α, and lowered oxidative markers with quercetin supplementation [94].